News Focus
News Focus
Followers 12
Posts 1019
Boards Moderated 0
Alias Born 03/24/2013

Re: DewDiligence post# 16700

Thursday, 03/02/2017 10:28:31 PM

Thursday, March 02, 2017 10:28:31 PM

Post# of 20689
M923 deal before FDA approval makes no sense. Difficult to assign value without knowing interchangeability status.

Other factor that may influence an early deal is cash depletion caused by long delay in glatopa 40mg approval.

There will be enough of interest in this asset & so MNTA will be in no hurry.